Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities-Reference-Cited by-同舟云学术

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities

Published:2019-08 Issue:8 Volume:6 Page:e552-e558
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Nachman Sharon,Townsend Claire L,Abrams Elaine J,Archary Moherndren,Capparelli Edmund,Clayden Polly,Lockman Shahin,Jean-Philippe Patrick,Mayer Kenneth,Mirochnick Mark,McKenzie-White Jane,Struble Kimberly,Watts Heather,Flexner Charles

Funder

Bill & Melinda Gates Foundation

National Institute of Allergy and Infectious Diseases

International Maternal Pediatric Adolescent AIDS Clinical Trials Network

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference32 articles.

1. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities;Zanoni;AIDS Patient Care STDS,2014

2. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis;Kim;AIDS,2014